

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook


IN BRIEF: Scancell turns once again to Durrant to lead company


(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on ...


IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK


IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares


AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact


IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares


IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares